Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan

Journal of Clinical Microbiology
Yu-Tsung HuangPo-Ren Hsueh

Abstract

We describe the development of nonsusceptibility to daptomycin and vancomycin during treatment for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia associated with infective endocarditis and probable septic thrombophlebitis in a uremic patient. MRSA bacteremia persisted during glycopeptide and subsequent daptomycin treatment but cleared after 5 days' treatment with linezolid and fusidic acid.

References

Oct 12, 2000·Diagnostic Microbiology and Infectious Disease·P C FuchsS D Brown
Oct 27, 2004·Emerging Infectious Diseases·Jiun-Ling WangKeiichi Hiramatsu
Feb 12, 2005·The Journal of Antimicrobial Chemotherapy·Judith N SteenbergenFrancis P Tally
Mar 29, 2005·The Lancet Infectious Diseases·Robert Ew Hancock
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A MangiliD H Hamer
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Tatiana BogdanovichPeter C Appelbaum
Oct 7, 2005·Journal of Clinical Microbiology·M K HaydenR A Weinstein
Feb 4, 2006·Journal of Clinical Microbiology·Daniel J Skiest
Mar 15, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·David HirschwerkSusan Condon
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·George SakoulasGeorge M Eliopoulos
May 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean B PatelFred C Tenover
May 26, 2006·Antimicrobial Agents and Chemotherapy·Lisa FriedmanJared A Silverman
Sep 12, 2006·International Journal of Antimicrobial Agents·Glenn W KaatzSusan M Seo
May 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Michael M MwangiAlexander Tomasz

❮ Previous
Next ❯

Citations

Nov 5, 2013·International Journal of Antimicrobial Agents·Viviana CafisoStefania Stefani
Mar 5, 2011·The Lancet Infectious Diseases·Guy E ThwaitesUNKNOWN UK Clinical Infection Research Group
Aug 21, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chin Chi KuoPo-Ren Hsueh
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·R E Warren
Mar 20, 2009·The Pediatric Infectious Disease Journal·Lara M JacobsonRavit Arav-Boger
Dec 14, 2011·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chung-Chih LaiShan-Chwen Chang
Aug 6, 2010·International Journal of Antimicrobial Agents·Po-Ren HsuehJang-Jih Lu
Aug 24, 2010·International Journal of Antimicrobial Agents·Floriana CampanileStefania Stefani
Mar 4, 2009·Enfermedades infecciosas y microbiología clínica·Francisco GudiolUNKNOWN Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Feb 9, 2012·Chemotherapy Research and Practice·Kristina Nadrah, Franc Strle
Jul 6, 2015·International Journal of Antimicrobial Agents·Stefania StefaniGiovanni Pacini
Sep 17, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Evangelo BoumisUNKNOWN GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Bloodstream Infections and Endocarditis
Oct 14, 2008·Expert Review of Anti-infective Therapy·Natasha V D V Ratnaraja, Peter M Hawkey
Oct 24, 2017·The Journal of Antimicrobial Chemotherapy·Mohsen HeidaryMehdi Goudarzi
Feb 20, 2009·Current Opinion in Otolaryngology & Head and Neck Surgery

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A MangiliD H Hamer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Benjamin P HowdenM Lindsay Grayson
© 2021 Meta ULC. All rights reserved